Inhibitors of Apoptotic Proteins: New Targets for Anticancer Therapy |
| |
| Authors: | Mohammad Saleem Muhammad Imran Qadir Nadia Perveen Bashir Ahmad Uzma Saleem Tehseen Irshad Bashir Ahmad |
| |
| Affiliation: | 1. College of Pharmacy, GC University, , Faisalabad, Pakistan;2. University College of Pharmacy, University of the Punjab, , Lahore, Pakistan;3. Foundation University Medical College, , Islamabad, Pakistan;4. Faculty of Pharmacy, Bahauddin Zakariya University, , Multan, Pakistan |
| |
| Abstract: | ![]()
Inhibitors of apoptotic proteins (IAPs) can play an important role in inhibiting apoptosis by exerting their negative action on caspases (apoptotic proteins). There are eight proteins in this family: NAIP/BIRC1/NLRB, cellular IAP1 (cIAP1)/human IAP2/BIRC2, cellular IAP2 (cIAP2)/human IAP1/BIRC3, X‐linked IAP (XIAP)/BIRC4, survivin/BIRC5, baculoviral IAP repeat (BIR)‐containing ubiquitin‐conjugating enzyme/apollon/BIRC6, livin/melanoma‐IAP (ML‐IAP)/BIRC7/KIAP, and testis‐specific IAP (Ts‐IAP)/hILP‐2/BIRC8. Deregulation of these inhibitors of apoptotic proteins (IAPs) may push cell toward cancer and neurodegenerative disorders. Inhibitors of apoptotic proteins (IAPs) may provide new target for anticancer therapy. Drugs may be developed that are inhibiting these IAPs to induce apoptosis in cancerous cells. |
| |
| Keywords: | baculovirus IAP repeat (BIR) BIR‐containing (BIRC) proteins inhibitors of apoptotic proteins (IAPs) |
|
|
